Clinical Trial Update: Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese Patients With Chronic Heart Failure

View source ↗

Summary

A post-market study assessing the performance of a multi-vector left ventricular lead in Chinese patients with chronic heart failure has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Multi-Vector Left Ventricular Lead

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Heart Failure | Status: COMPLETED | Results posted: 2020-11-18